vs

Side-by-side financial comparison of MACERICH CO (MAC) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

MACERICH CO is the larger business by last-quarter revenue ($261.7M vs $142.0M, roughly 1.8× Oncology Institute, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -7.2%, a 1.9% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -4.4%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 12.0%).

The Macerich Company is a real estate investment trust that invests in shopping centers. It is the third-largest owner and operator of shopping centers in the United States. As of December 31, 2024, the company owned interests in 43 properties comprising 43 million square feet of leasable area. The company name is a portmanteau of its founders, Mace Siegel and Richard Cohen.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

MAC vs TOI — Head-to-Head

Bigger by revenue
MAC
MAC
1.8× larger
MAC
$261.7M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+46.0% gap
TOI
41.6%
-4.4%
MAC
Higher net margin
TOI
TOI
1.9% more per $
TOI
-5.3%
-7.2%
MAC
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
12.0%
MAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MAC
MAC
TOI
TOI
Revenue
$261.7M
$142.0M
Net Profit
$-18.8M
$-7.5M
Gross Margin
Operating Margin
-4.9%
Net Margin
-7.2%
-5.3%
Revenue YoY
-4.4%
41.6%
Net Profit YoY
91.1%
43.0%
EPS (diluted)
$-0.08
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MAC
MAC
TOI
TOI
Q4 25
$261.7M
$142.0M
Q3 25
$253.3M
$136.6M
Q2 25
$249.8M
$119.8M
Q1 25
$249.2M
$104.4M
Q4 24
$273.7M
$100.3M
Q3 24
$220.2M
$99.9M
Q2 24
$215.5M
$98.6M
Q1 24
$208.8M
$94.7M
Net Profit
MAC
MAC
TOI
TOI
Q4 25
$-18.8M
$-7.5M
Q3 25
$-87.4M
$-16.5M
Q2 25
$-40.9M
$-17.0M
Q1 25
$-50.1M
$-19.6M
Q4 24
$-211.2M
$-13.2M
Q3 24
$-108.2M
$-16.1M
Q2 24
$252.0M
$-15.5M
Q1 24
$-126.7M
$-19.9M
Operating Margin
MAC
MAC
TOI
TOI
Q4 25
-4.9%
Q3 25
-5.9%
Q2 25
-9.4%
Q1 25
-9.5%
Q4 24
-11.9%
Q3 24
-13.9%
Q2 24
-16.6%
Q1 24
-19.0%
Net Margin
MAC
MAC
TOI
TOI
Q4 25
-7.2%
-5.3%
Q3 25
-34.5%
-12.1%
Q2 25
-16.4%
-14.2%
Q1 25
-20.1%
-18.8%
Q4 24
-77.2%
-13.1%
Q3 24
-49.1%
-16.1%
Q2 24
116.9%
-15.7%
Q1 24
-60.7%
-21.0%
EPS (diluted)
MAC
MAC
TOI
TOI
Q4 25
$-0.08
$-0.04
Q3 25
$-0.34
$-0.14
Q2 25
$-0.16
$-0.15
Q1 25
$-0.20
$-0.21
Q4 24
$-0.95
$-0.14
Q3 24
$-0.50
$-0.18
Q2 24
$1.16
$-0.17
Q1 24
$-0.59
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MAC
MAC
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$280.2M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$2.4B
$-15.7M
Total Assets
$8.4B
$164.7M
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MAC
MAC
TOI
TOI
Q4 25
$280.2M
Q3 25
$290.2M
Q2 25
$131.1M
Q1 25
$253.2M
Q4 24
$89.9M
Q3 24
$116.5M
Q2 24
$70.7M
$9.9M
Q1 24
$120.1M
$29.8M
Total Debt
MAC
MAC
TOI
TOI
Q4 25
$5.1B
Q3 25
$5.1B
Q2 25
$5.2B
Q1 25
$5.2B
Q4 24
$4.9B
Q3 24
$4.3B
Q2 24
$4.4B
Q1 24
$4.1B
Stockholders' Equity
MAC
MAC
TOI
TOI
Q4 25
$2.4B
$-15.7M
Q3 25
$2.5B
$-12.3M
Q2 25
$2.6B
$-9.0M
Q1 25
$2.7B
$5.1M
Q4 24
$2.8B
$3.6M
Q3 24
$2.5B
$15.5M
Q2 24
$2.5B
$29.2M
Q1 24
$2.3B
$41.3M
Total Assets
MAC
MAC
TOI
TOI
Q4 25
$8.4B
$164.7M
Q3 25
$8.4B
$163.6M
Q2 25
$8.7B
$159.8M
Q1 25
$8.7B
$164.0M
Q4 24
$8.6B
$172.7M
Q3 24
$7.6B
$179.2M
Q2 24
$7.8B
$179.6M
Q1 24
$7.4B
$204.5M
Debt / Equity
MAC
MAC
TOI
TOI
Q4 25
2.07×
Q3 25
2.02×
Q2 25
2.02×
Q1 25
1.96×
Q4 24
1.78×
Q3 24
1.73×
Q2 24
1.75×
Q1 24
1.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MAC
MAC
TOI
TOI
Operating Cash FlowLast quarter
$50.2M
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MAC
MAC
TOI
TOI
Q4 25
$50.2M
$3.2M
Q3 25
$112.4M
$-12.6M
Q2 25
$70.5M
$-10.2M
Q1 25
$88.5M
$-5.0M
Q4 24
$54.9M
$4.2M
Q3 24
$100.0M
$819.0K
Q2 24
$67.4M
$-15.7M
Q1 24
$61.1M
$-15.9M
Free Cash Flow
MAC
MAC
TOI
TOI
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$-11.4M
Q1 25
$-5.3M
Q4 24
$2.4M
Q3 24
$417.0K
Q2 24
$-17.5M
Q1 24
$-16.5M
FCF Margin
MAC
MAC
TOI
TOI
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
-9.5%
Q1 25
-5.1%
Q4 24
2.4%
Q3 24
0.4%
Q2 24
-17.7%
Q1 24
-17.4%
Capex Intensity
MAC
MAC
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.8%
Q3 24
0.4%
Q2 24
1.9%
Q1 24
0.6%
Cash Conversion
MAC
MAC
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MAC
MAC

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons